graphite/kegg PI3K-Akt signaling pathway: Inhibited, FDR = 0.00103, FWER = 0.0103, PValue = 7.1e-05
TLR2: 8.94-fold Up; FDR = 6.97e-23; PValue = 1.25e-25; mean CPM = 18.41; toll-like receptor 2
CSF1: 7.34-fold Up; FDR = 4.6e-20; PValue = 1.69e-22; mean CPM = 149.8; colony stimulating factor 1 (macrophage)
JAK2: 3.64-fold Up; FDR = 1.88e-18; PValue = 1.01e-20; mean CPM = 56.10; Janus kinase 2
COL4A1: 7.03-fold Down; FDR = 1.47e-15; PValue = 1.34e-17; mean CPM = 3419; collagen, type IV, alpha 1
COL5A1: 4.69-fold Down; FDR = 3.09e-15; PValue = 2.99e-17; mean CPM = 1718; collagen, type V, alpha 1
COL3A1: 20.5-fold Down; FDR = 5.71e-15; PValue = 5.82e-17; mean CPM = 5961; collagen, type III, alpha 1
COL11A1: 12.2-fold Down; FDR = 8.67e-15; PValue = 9.24e-17; mean CPM = 318.0; collagen, type XI, alpha 1
ITGA5: 3.79-fold Down; FDR = 1.33e-14; PValue = 1.48e-16; mean CPM = 1237; integrin, alpha 5 (fibronectin receptor, alpha polypeptide)
PDGFRA: 2.76-fold Up; FDR = 3.93e-14; PValue = 4.67e-16; mean CPM = 492.9; platelet-derived growth factor receptor, alpha polypeptide
COL6A3: 4.93-fold Down; FDR = 5.63e-14; PValue = 6.87e-16; mean CPM = 1415; collagen, type VI, alpha 3
FGF1: 5.05-fold Down; FDR = 8.21e-14; PValue = 1.05e-15; mean CPM = 19.54; fibroblast growth factor 1 (acidic)
COL1A1: 21.5-fold Down; FDR = 1.13e-13; PValue = 1.5e-15; mean CPM = 15389; collagen, type I, alpha 1
GNG10: 2.27-fold Up; FDR = 1.24e-13; PValue = 1.66e-15; mean CPM = 24.29; guanine nucleotide binding protein (G protein), gamma 10
VEGFC: 2-fold Up; FDR = 1.3e-13; PValue = 1.76e-15; mean CPM = 238.4; Macaca mulatta vascular endothelial growth factor C (VEGFC), mRNA.
IL7: 9.03-fold Up; FDR = 1.39e-13; PValue = 1.9e-15; mean CPM = 5.288; interleukin 7
MET: 2.57-fold Up; FDR = 3.56e-13; PValue = 5.22e-15; mean CPM = 242.4; Macaca mulatta met proto-oncogene (hepatocyte growth factor receptor) (MET), mRNA.
COL1A2: 10.7-fold Down; FDR = 3.82e-13; PValue = 5.68e-15; mean CPM = 17923; collagen, type I, alpha 2
LAMC1: 2.28-fold Down; FDR = 6.46e-13; PValue = 1.01e-14; mean CPM = 812.1; laminin, gamma 1 (formerly LAMB2)
EPHA2: 2.06-fold Down; FDR = 4.54e-12; PValue = 8.63e-14; mean CPM = 77.86; EPH receptor A2
CREB3L2: 2.11-fold Down; FDR = 5.05e-12; PValue = 9.78e-14; mean CPM = 64.33; cAMP responsive element binding protein 3-like 2
ENSMMUP00000016591: 4.2-fold Down; FDR = 1.3e-11; PValue = 2.78e-13; mean CPM = 34.90; Uncharacterized protein
ENSMMUP00000016587: 4.92-fold Down; FDR = 1.6e-11; PValue = 3.5e-13; mean CPM = 51.70; Uncharacterized protein
ITGAV: 2.64-fold Down; FDR = 6.04e-11; PValue = 1.51e-12; mean CPM = 337.3; integrin, alpha V (vitronectin receptor, alpha polypeptide, antigen CD51)
PKN2: 1.67-fold Up; FDR = 6.49e-11; PValue = 1.64e-12; mean CPM = 64.77; protein kinase N2
CCND3: 2.27-fold Down; FDR = 8.38e-11; PValue = 2.15e-12; mean CPM = 86.90; cyclin D3
COL5A3: 5.21-fold Down; FDR = 1.78e-10; PValue = 4.98e-12; mean CPM = 79.70; collagen, type V, alpha 3
THBS2: 6.46-fold Down; FDR = 3.61e-10; PValue = 1.1e-11; mean CPM = 199.9; thrombospondin 2
ITGB8: 3.97-fold Up; FDR = 6.37e-10; PValue = 2.06e-11; mean CPM = 11.37; integrin, beta 8
ITGA2: 2.84-fold Up; FDR = 7.38e-10; PValue = 2.42e-11; mean CPM = 176.3; integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor)
CREB3L1: 1.99-fold Down; FDR = 1.52e-09; PValue = 5.36e-11; mean CPM = 211.4; cAMP responsive element binding protein 3-like 1
ITGB3: 5.02-fold Down; FDR = 1.72e-09; PValue = 6.17e-11; mean CPM = 43.21; integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)
COL5A2: 2.25-fold Down; FDR = 2.26e-09; PValue = 8.27e-11; mean CPM = 2999; collagen, type V, alpha 2
GNB4: 2.14-fold Up; FDR = 2.52e-09; PValue = 9.35e-11; mean CPM = 33.45; guanine nucleotide binding protein (G protein), beta polypeptide 4
TLR4: 3.45-fold Up; FDR = 3.1e-09; PValue = 1.19e-10; mean CPM = 7.456; Macaca mulatta toll-like receptor 4 (TLR4), mRNA.
SOS1: 1.69-fold Up; FDR = 4.45e-09; PValue = 1.77e-10; mean CPM = 47.70; son of sevenless homolog 1 (Drosophila)
EGFR: 1.84-fold Up; FDR = 6.71e-09; PValue = 2.77e-10; mean CPM = 68.58; epidermal growth factor receptor (erythroblastic leukemia viral (v-erb-b) oncogene homolog, avian)
IRS1: 2.78-fold Up; FDR = 7.67e-09; PValue = 3.19e-10; mean CPM = 26.55; Uncharacterized protein
ITGB5: 1.61-fold Down; FDR = 8.23e-09; PValue = 3.47e-10; mean CPM = 471.0; integrin, beta 5
FGF2: 2.42-fold Up; FDR = 9.98e-09; PValue = 4.31e-10; mean CPM = 134.8; fibroblast growth factor 2 (basic)
FGFR2: 3.45-fold Down; FDR = 1.04e-08; PValue = 4.53e-10; mean CPM = 5.064; fibroblast growth factor receptor 2
CDKN1B: 1.64-fold Up; FDR = 1.22e-08; PValue = 5.39e-10; mean CPM = 32.96; Cyclin-dependent kinase inhibitor 1B; Uncharacterized protein
INSR: 1.93-fold Down; FDR = 1.24e-08; PValue = 5.48e-10; mean CPM = 118.3; insulin receptor
ITGA10: 4.95-fold Down; FDR = 1.77e-08; PValue = 8.13e-10; mean CPM = 5.184; integrin, alpha 10
RELA: 1.55-fold Up; FDR = 3.47e-08; PValue = 1.74e-09; mean CPM = 86.96; v-rel reticuloendotheliosis viral oncogene homolog A (avian)
ITGA8: 4.04-fold Down; FDR = 5.89e-08; PValue = 3.12e-09; mean CPM = 145.8; integrin, alpha 8
THBS3: 1.97-fold Up; FDR = 7.19e-08; PValue = 3.88e-09; mean CPM = 128.6; thrombospondin 3
COMP: 4.64-fold Down; FDR = 7.47e-08; PValue = 4.04e-09; mean CPM = 13.27; cartilage oligomeric matrix protein
EFNA4: 3.75-fold Down; FDR = 2.37e-07; PValue = 1.45e-08; mean CPM = 2.749; ephrin-A4
PDGFA: 1.92-fold Down; FDR = 2.56e-07; PValue = 1.58e-08; mean CPM = 22.99; platelet-derived growth factor alpha polypeptide
GNG11: 1.65-fold Up; FDR = 2.71e-07; PValue = 1.68e-08; mean CPM = 86.60; guanine nucleotide binding protein (G protein), gamma 11
TNC: 1.97-fold Down; FDR = 4.07e-07; PValue = 2.63e-08; mean CPM = 2667; tenascin C
PIK3R2: 1.53-fold Down; FDR = 4.32e-07; PValue = 2.82e-08; mean CPM = 31.53; Phosphatidylinositol 3-kinase regulatory subunit beta; Uncharacterized protein
BCL2L1: 1.51-fold Up; FDR = 9.13e-07; PValue = 6.52e-08; mean CPM = 66.15; Bcl-2-like protein 1; Bcl-2-like protein 1 isoform 1; Uncharacterized protein
PIK3CA: 1.47-fold Up; FDR = 1.39e-06; PValue = 1.03e-07; mean CPM = 55.32; phosphoinositide-3-kinase, catalytic, alpha polypeptide
AKT2: 1.46-fold Down; FDR = 1.51e-06; PValue = 1.13e-07; mean CPM = 65.98; v-akt murine thymoma viral oncogene homolog 2
THBS1: 2.74-fold Down; FDR = 1.68e-06; PValue = 1.28e-07; mean CPM = 25785; thrombospondin 1
IFNAR2: 1.74-fold Up; FDR = 1.85e-06; PValue = 1.44e-07; mean CPM = 26.05; interferon (alpha, beta and omega) receptor 2
FGFR3: 3.85-fold Down; FDR = 2.66e-06; PValue = 2.13e-07; mean CPM = 2.800; fibroblast growth factor receptor 3
COL4A5: 2.03-fold Down; FDR = 3.06e-06; PValue = 2.48e-07; mean CPM = 9.810; collagen, type IV, alpha 5
PRKAA2: 1.7-fold Down; FDR = 5.6e-06; PValue = 4.89e-07; mean CPM = 11.23; protein kinase, AMP-activated, alpha 2 catalytic subunit
COL6A1: 1.85-fold Down; FDR = 6.65e-06; PValue = 5.96e-07; mean CPM = 1937; collagen, type VI, alpha 1
IGF1: 5.76-fold Down; FDR = 6.73e-06; PValue = 6.04e-07; mean CPM = 1.536; insulin-like growth factor 1 (somatomedin C)
LAMC2: 2.28-fold Down; FDR = 9.83e-06; PValue = 9.24e-07; mean CPM = 16.99; laminin, gamma 2
TSC2: 1.44-fold Down; FDR = 1e-05; PValue = 9.42e-07; mean CPM = 124.0; tuberous sclerosis 2
IGF1R: 1.51-fold Down; FDR = 1.02e-05; PValue = 9.61e-07; mean CPM = 213.2; insulin-like growth factor 1 receptor
MAP2K1: 1.41-fold Up; FDR = 1.41e-05; PValue = 1.37e-06; mean CPM = 103.2; mitogen-activated protein kinase kinase 1
OSMR: 1.49-fold Up; FDR = 1.63e-05; PValue = 1.62e-06; mean CPM = 180.8; Uncharacterized protein
RPTOR: 1.4-fold Down; FDR = 2.58e-05; PValue = 2.69e-06; mean CPM = 53.57; regulatory associated protein of MTOR, complex 1
DDIT4: 1.72-fold Up; FDR = 4.15e-05; PValue = 4.58e-06; mean CPM = 395.1; DNA-damage-inducible transcript 4
HSP90AA1: 1.41-fold Up; FDR = 4.17e-05; PValue = 4.62e-06; mean CPM = 609.6; heat shock protein 90kDa alpha (cytosolic), class A member 2
PPP2R1B: 1.39-fold Down; FDR = 4.37e-05; PValue = 4.86e-06; mean CPM = 233.1; protein phosphatase 2, regulatory subunit A, beta
RPS6KB2: 1.38-fold Down; FDR = 4.66e-05; PValue = 5.24e-06; mean CPM = 61.90; ribosomal protein S6 kinase, 70kDa, polypeptide 2
IL6R: 3.84-fold Down; FDR = 6.68e-05; PValue = 7.89e-06; mean CPM = 4.840; interleukin 6 receptor
PPP2R3C: 1.5-fold Up; FDR = 7.46e-05; PValue = 8.92e-06; mean CPM = 15.53; protein phosphatase 2 (formerly 2A), regulatory subunit B'', gamma
SPP1: 2.25-fold Down; FDR = 7.74e-05; PValue = 9.29e-06; mean CPM = 35.33; secreted phosphoprotein 1
PCK2: 1.8-fold Up; FDR = 8.33e-05; PValue = 1.01e-05; mean CPM = 110.4; phosphoenolpyruvate carboxykinase 2 (mitochondrial)
PPP2R5A: 1.45-fold Up; FDR = 0.000141; PValue = 1.83e-05; mean CPM = 21.64; protein phosphatase 2, regulatory subunit B', alpha
GNB3: 1.91-fold Down; FDR = 0.000162; PValue = 2.14e-05; mean CPM = 7.202; guanine nucleotide binding protein (G protein), beta polypeptide 3
PPP2CB: 1.35-fold Up; FDR = 0.000215; PValue = 2.96e-05; mean CPM = 59.68; protein phosphatase 2, catalytic subunit, beta isozyme
G6PC3: 1.37-fold Down; FDR = 0.000225; PValue = 3.11e-05; mean CPM = 33.42; glucose 6 phosphatase, catalytic, 3
CREB5: 2.1-fold Down; FDR = 0.000248; PValue = 3.48e-05; mean CPM = 4.269; cAMP responsive element binding protein 5
COL6A2: 1.47-fold Down; FDR = 0.000287; PValue = 4.1e-05; mean CPM = 1544; collagen, type VI, alpha 2
VEGFA: 1.47-fold Up; FDR = 0.000317; PValue = 4.59e-05; mean CPM = 463.7; vascular endothelial growth factor A
HGF: 1.85-fold Down; FDR = 0.000377; PValue = 5.58e-05; mean CPM = 137.4; hepatocyte growth factor (hepapoietin A; scatter factor)
LAMB2: 1.48-fold Down; FDR = 0.000398; PValue = 5.93e-05; mean CPM = 695.6; laminin, beta 2 (laminin S)
ATF2: 1.34-fold Up; FDR = 0.000403; PValue = 6.01e-05; mean CPM = 39.83; activating transcription factor 2
ITGA3: 1.34-fold Down; FDR = 0.000518; PValue = 7.96e-05; mean CPM = 126.8; integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor)
PPP2R2B: 7.66-fold Down; FDR = 0.000564; PValue = 8.78e-05; mean CPM = 4.510; protein phosphatase 2, regulatory subunit B, beta
BAD: 1.36-fold Down; FDR = 0.000605; PValue = 9.52e-05; mean CPM = 48.46; BCL2-associated agonist of cell death
PRKAA1: 1.32-fold Up; FDR = 0.000825; PValue = 0.000135; mean CPM = 40.69; protein kinase, AMP-activated, alpha 1 catalytic subunit
ANGPT4: 4.02-fold Down; FDR = 0.000955; PValue = 0.00016; mean CPM = 1.231; angiopoietin 4
NR4A1: 1.74-fold Down; FDR = 0.00108; PValue = 0.000184; mean CPM = 312.6; nuclear receptor subfamily 4, group A, member 1
MTOR: 1.3-fold Down; FDR = 0.00117; PValue = 0.000201; mean CPM = 107.5; mechanistic target of rapamycin (serine/threonine kinase)
JAK3: 2.31-fold Up; FDR = 0.00186; PValue = 0.000342; mean CPM = 2.154; Janus kinase 3
NGF: 1.32-fold Up; FDR = 0.00212; PValue = 0.000396; mean CPM = 198.5; nerve growth factor (beta polypeptide)
EIF4E2: 1.3-fold Down; FDR = 0.00249; PValue = 0.000475; mean CPM = 29.85; eukaryotic translation initiation factor 4E family member 2
OSM: 4.6-fold Down; FDR = 0.00251; PValue = 0.00048; mean CPM = 0.9104; oncostatin M
ATF4: 1.29-fold Up; FDR = 0.00296; PValue = 0.000579; mean CPM = 618.7; activating transcription factor 4 (tax-responsive enhancer element B67)
PKN3: 1.86-fold Down; FDR = 0.00308; PValue = 0.000604; mean CPM = 5.065; protein kinase N3
CSF1R: 1.92-fold Down; FDR = 0.00308; PValue = 0.000604; mean CPM = 3.242; colony stimulating factor 1 receptor
EFNA2: 4.72-fold Down; FDR = 0.00348; PValue = 0.000699; mean CPM = 1.248; ephrin-A2
ITGB4: 1.66-fold Down; FDR = 0.00369; PValue = 0.000748; mean CPM = 5.291; integrin, beta 4
GNG12: 1.31-fold Up; FDR = 0.00387; PValue = 0.000792; mean CPM = 24.97; guanine nucleotide binding protein (G protein), gamma 12
SGK1: 1.36-fold Down; FDR = 0.0048; PValue = 0.00101; mean CPM = 395.0; Uncharacterized protein
PPP2R5D: 1.27-fold Down; FDR = 0.00482; PValue = 0.00101; mean CPM = 35.61; protein phosphatase 2, regulatory subunit B', delta
HSP90B1: 1.28-fold Down; FDR = 0.00538; PValue = 0.00115; mean CPM = 1017; heat shock protein 90kDa beta (Grp94), member 1
MDM2: 1.32-fold Up; FDR = 0.00555; PValue = 0.00119; mean CPM = 148.6; Uncharacterized protein
FGF12: 1.26-fold Up; FDR = 0.00782; PValue = 0.00177; mean CPM = 34.71; fibroblast growth factor 12
IFNAR1: 1.27-fold Up; FDR = 0.0101; PValue = 0.00237; mean CPM = 82.39; Uncharacterized protein
EFNA3: 2.71-fold Down; FDR = 0.0114; PValue = 0.00271; mean CPM = 1.699; ephrin-A3
EFNA1: 2.73-fold Down; FDR = 0.0114; PValue = 0.00272; mean CPM = 1.130; ephrin-A1
PDGFB: 1.97-fold Down; FDR = 0.0133; PValue = 0.00326; mean CPM = 2.424; platelet-derived growth factor beta polypeptide (simian sarcoma viral (v-sis) oncogene homolog)
EPOR: 1.56-fold Down; FDR = 0.014; PValue = 0.00347; mean CPM = 3.898; erythropoietin receptor
CDC37: 1.23-fold Down; FDR = 0.0152; PValue = 0.00381; mean CPM = 275.9; cell division cycle 37 homolog (S. cerevisiae)
PRKCZ: 1.51-fold Up; FDR = 0.0152; PValue = 0.00381; mean CPM = 10.46; protein kinase C, zeta
FN1: 1.7-fold Down; FDR = 0.0164; PValue = 0.00417; mean CPM = 40317; fibronectin 1
ITGA2B: 1.71-fold Down; FDR = 0.0187; PValue = 0.00486; mean CPM = 2.655; integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41)
CDK2: 1.23-fold Down; FDR = 0.0194; PValue = 0.00507; mean CPM = 36.76; cyclin-dependent kinase 2
MAPK1: 1.22-fold Up; FDR = 0.0198; PValue = 0.00522; mean CPM = 56.44; mitogen-activated protein kinase 1
AKT1: 1.21-fold Down; FDR = 0.0257; PValue = 0.00703; mean CPM = 165.7; v-akt murine thymoma viral oncogene homolog 1
FGF21: 1.97-fold Up; FDR = 0.0263; PValue = 0.00722; mean CPM = 56.49; fibroblast growth factor 21
CREB1: 1.21-fold Up; FDR = 0.0313; PValue = 0.00884; mean CPM = 36.07; cAMP responsive element binding protein 1
KDR: 2.01-fold Up; FDR = 0.0328; PValue = 0.00936; mean CPM = 2.053; kinase insert domain receptor (a type III receptor tyrosine kinase)
MCL1: 1.2-fold Up; FDR = 0.0335; PValue = 0.00961; mean CPM = 193.8; myeloid cell leukemia sequence 1 (BCL2-related)
PDPK1: 1.24-fold Down; FDR = 0.0361; PValue = 0.0105; mean CPM = 17.53; 3-phosphoinositide dependent protein kinase-1
COL2A1: 2.38-fold Down; FDR = 0.0368; PValue = 0.0107; mean CPM = 1.117; Uncharacterized protein
NFKB1: 1.2-fold Down; FDR = 0.039; PValue = 0.0115; mean CPM = 72.10; nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
KRAS: 1.35-fold Down; FDR = 0.0401; PValue = 0.0119; mean CPM = 13.10; v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog
NRAS: 1.2-fold Down; FDR = 0.0546; PValue = 0.017; mean CPM = 32.39; neuroblastoma RAS viral (v-ras) oncogene homolog
TSC1: 1.19-fold Down; FDR = 0.0564; PValue = 0.0177; mean CPM = 38.34; tuberous sclerosis 1
YWHAH: 1.18-fold Down; FDR = 0.057; PValue = 0.018; mean CPM = 69.27; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide
BCL2L11: 1.34-fold Up; FDR = 0.0609; PValue = 0.0195; mean CPM = 18.38; BCL2-like 11 (apoptosis facilitator)
PHLPP2: 1.19-fold Down; FDR = 0.0673; PValue = 0.0219; mean CPM = 33.67; PH domain and leucine rich repeat protein phosphatase 2
MYC: 1.18-fold Up; FDR = 0.0688; PValue = 0.0225; mean CPM = 161.3; Macaca mulatta v-myc myelocytomatosis viral oncogene homolog (avian) (MYC), mRNA.
IL7R: 1.76-fold Down; FDR = 0.0698; PValue = 0.0229; mean CPM = 3.067; interleukin 7 receptor
CSF3: 2.55-fold Up; FDR = 0.0701; PValue = 0.023; mean CPM = 72.12; colony stimulating factor 3 (granulocyte)
HRAS: 1.18-fold Down; FDR = 0.0703; PValue = 0.0231; mean CPM = 36.86; v-Ha-ras Harvey rat sarcoma viral oncogene homolog
EIF4EBP1: 1.23-fold Up; FDR = 0.0729; PValue = 0.0241; mean CPM = 40.55; eukaryotic translation initiation factor 4E binding protein 1
ITGB1: 1.23-fold Up; FDR = 0.0759; PValue = 0.0253; mean CPM = 2700; integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)
RXRA: 1.18-fold Down; FDR = 0.077; PValue = 0.0257; mean CPM = 35.60; retinoid X receptor, alpha
LAMA4: 1.2-fold Down; FDR = 0.0793; PValue = 0.0266; mean CPM = 624.4; laminin, alpha 4
FGF11: 1.44-fold Down; FDR = 0.0841; PValue = 0.0285; mean CPM = 3.869; fibroblast growth factor 11
SGK3: 1.34-fold Up; FDR = 0.0916; PValue = 0.0316; mean CPM = 5.230; serum/glucocorticoid regulated kinase family, member 3
JAK1: 1.17-fold Up; FDR = 0.0944; PValue = 0.0327; mean CPM = 243.5; Tyrosine-protein kinase
CREB3L4: 1.3-fold Down; FDR = 0.0961; PValue = 0.0334; mean CPM = 6.034; cAMP responsive element binding protein 3-like 4
CRTC2: 1.18-fold Up; FDR = 0.0976; PValue = 0.0341; mean CPM = 27.36; CREB regulated transcription coactivator 2
SOS2: 1.17-fold Up; FDR = 0.1; PValue = 0.0353; mean CPM = 31.79; son of sevenless homolog 2 (Drosophila)
PIK3AP1: 2.18-fold Up; FDR = 0.108; PValue = 0.0384; mean CPM = 1.085; phosphoinositide-3-kinase adaptor protein 1
PPP2R5E: 1.17-fold Up; FDR = 0.112; PValue = 0.04; mean CPM = 30.87; Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit epsilon isoform; Uncharacterized protein
IKBKB: 1.16-fold Up; FDR = 0.116; PValue = 0.0418; mean CPM = 44.75; inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta
GNG2: 1.64-fold Up; FDR = 0.117; PValue = 0.0421; mean CPM = 2.320; guanine nucleotide binding protein (G protein), gamma 2
MYB: 1.85-fold Down; FDR = 0.12; PValue = 0.0437; mean CPM = 1.320; v-myb myeloblastosis viral oncogene homolog (avian)
CCND1: 1.17-fold Up; FDR = 0.121; PValue = 0.0443; mean CPM = 867.3; cyclin D1
CREB3: 1.15-fold Up; FDR = 0.128; PValue = 0.0472; mean CPM = 167.9; cAMP responsive element binding protein 3
IBSP: 2.51-fold Down; FDR = 0.128; PValue = 0.0476; mean CPM = 0.8896; integrin-binding sialoprotein
GSK3B: 1.18-fold Up; FDR = 0.137; PValue = 0.0515; mean CPM = 16.89; glycogen synthase kinase 3 beta
FGFR1: 1.15-fold Down; FDR = 0.139; PValue = 0.0525; mean CPM = 89.41; fibroblast growth factor receptor 1
GNG3: 1.6-fold Down; FDR = 0.155; PValue = 0.0601; mean CPM = 1.706; guanine nucleotide binding protein (G protein), gamma 3
YWHAG: 1.14-fold Down; FDR = 0.162; PValue = 0.0632; mean CPM = 175.7; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, gamma polypeptide
PTEN: 1.14-fold Up; FDR = 0.166; PValue = 0.065; mean CPM = 89.60; phosphatase and tensin homolog
VWF: 1.42-fold Down; FDR = 0.174; PValue = 0.069; mean CPM = 24.05; von Willebrand factor
FGF23: 2.01-fold Down; FDR = 0.188; PValue = 0.0759; mean CPM = 0.9718; fibroblast growth factor 23
RHEB: 1.13-fold Up; FDR = 0.193; PValue = 0.0785; mean CPM = 118.9; Ras homolog enriched in brain
TEK: 1.58-fold Down; FDR = 0.196; PValue = 0.0803; mean CPM = 2.573; TEK tyrosine kinase, endothelial
GRB2: 1.13-fold Up; FDR = 0.197; PValue = 0.0808; mean CPM = 46.42; growth factor receptor-bound protein 2
KITLG: 1.31-fold Up; FDR = 0.209; PValue = 0.0867; mean CPM = 5.766; KIT ligand
YWHAQ: 1.13-fold Up; FDR = 0.216; PValue = 0.0903; mean CPM = 187.3; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, theta polypeptide
SGK2: 2.06-fold Down; FDR = 0.225; PValue = 0.0952; mean CPM = 0.9494; serum/glucocorticoid regulated kinase 2
LAMB4: 1.81-fold Down; FDR = 0.237; PValue = 0.101; mean CPM = 1.043; laminin, beta 4
MTCP1: 1.42-fold Up; FDR = 0.248; PValue = 0.107; mean CPM = 2.103; mature T-cell proliferation 1
FGF10: 1.55-fold Down; FDR = 0.257; PValue = 0.112; mean CPM = 3.488; fibroblast growth factor 10
CCNE1: 1.2-fold Up; FDR = 0.278; PValue = 0.123; mean CPM = 6.609; cyclin E1
CDKN1A: 1.16-fold Down; FDR = 0.28; PValue = 0.124; mean CPM = 363.2; Cyclin-dependent kinase inhibitor 1; Uncharacterized protein
AKT3: 1.13-fold Down; FDR = 0.281; PValue = 0.125; mean CPM = 38.03; v-akt murine thymoma viral oncogene homolog 3 (protein kinase B, gamma)
NGFR: 1.72-fold Down; FDR = 0.285; PValue = 0.127; mean CPM = 1.174; nerve growth factor receptor
CDK6: 1.18-fold Down; FDR = 0.301; PValue = 0.136; mean CPM = 26.51; cyclin-dependent kinase 6
ENSMMUP00000014969: 1.93-fold Down; FDR = 0.303; PValue = 0.137; mean CPM = 0.9384; Uncharacterized protein
LAMB3: 1.6-fold Down; FDR = 0.303; PValue = 0.137; mean CPM = 1.445; laminin, beta 3
PIK3CG: 1.88-fold Up; FDR = 0.332; PValue = 0.154; mean CPM = 0.9143; phosphoinositide-3-kinase, catalytic, gamma polypeptide
CCND2: 1.2-fold Up; FDR = 0.335; PValue = 0.155; mean CPM = 76.91; cyclin D2
COL6A6: 1.78-fold Down; FDR = 0.354; PValue = 0.166; mean CPM = 0.9461; collagen, type VI, alpha 6
TP53: 1.11-fold Down; FDR = 0.364; PValue = 0.172; mean CPM = 33.25; tumor protein p53
GNG7: 1.75-fold Down; FDR = 0.366; PValue = 0.174; mean CPM = 0.9647; guanine nucleotide binding protein (G protein), gamma 7
GHR: 1.23-fold Up; FDR = 0.369; PValue = 0.175; mean CPM = 6.312; growth hormone receptor
PIK3CB: 1.13-fold Down; FDR = 0.383; PValue = 0.183; mean CPM = 21.07; phosphoinositide-3-kinase, catalytic, beta polypeptide
BCL2: 1.48-fold Up; FDR = 0.384; PValue = 0.184; mean CPM = 1.344; Uncharacterized protein
EPO: 1.77-fold Up; FDR = 0.39; PValue = 0.188; mean CPM = 0.9174; Macaca mulatta erythropoietin (EPO), mRNA.
PPP2R2C: 1.48-fold Up; FDR = 0.391; PValue = 0.188; mean CPM = 1.318; protein phosphatase 2, regulatory subunit B, gamma
PPP2R5C: 1.14-fold Up; FDR = 0.391; PValue = 0.189; mean CPM = 54.95; protein phosphatase 2, regulatory subunit B', gamma
PTK2: 1.1-fold Up; FDR = 0.394; PValue = 0.191; mean CPM = 102.5; PTK2 protein tyrosine kinase 2
GYS1: 1.1-fold Down; FDR = 0.405; PValue = 0.197; mean CPM = 143.6; glycogen synthase 1 (muscle)
COL4A3: 1.67-fold Down; FDR = 0.422; PValue = 0.207; mean CPM = 0.9315; collagen, type IV, alpha 3 (Goodpasture antigen)
TNN: 1.32-fold Up; FDR = 0.425; PValue = 0.209; mean CPM = 2.061; tenascin N
LPAR3: 2.49-fold Down; FDR = 0.429; PValue = 0.212; mean CPM = 0.8456; lysophosphatidic acid receptor 3
RBL2: 1.09-fold Up; FDR = 0.445; PValue = 0.222; mean CPM = 47.90; retinoblastoma-like 2 (p130)
MAPK3: 1.09-fold Up; FDR = 0.45; PValue = 0.225; mean CPM = 65.52; mitogen-activated protein kinase 3
F2R: 1.1-fold Up; FDR = 0.458; PValue = 0.23; mean CPM = 35.05; coagulation factor II (thrombin) receptor
ENSMMUP00000026812: 1.61-fold Down; FDR = 0.46; PValue = 0.232; mean CPM = 0.9948; Uncharacterized protein
THBS4: 1.64-fold Down; FDR = 0.498; PValue = 0.257; mean CPM = 0.9543; thrombospondin 4
ANGPT1: 1.13-fold Up; FDR = 0.503; PValue = 0.26; mean CPM = 28.18; angiopoietin 1
VEGFB: 1.1-fold Down; FDR = 0.512; PValue = 0.267; mean CPM = 16.03; vascular endothelial growth factor B
GNG4: 1.65-fold Down; FDR = 0.524; PValue = 0.275; mean CPM = 0.8771; guanine nucleotide binding protein (G protein), gamma 4
PIK3R5: 1.45-fold Up; FDR = 0.53; PValue = 0.279; mean CPM = 1.188; phosphoinositide-3-kinase, regulatory subunit 5
FGF18: 1.55-fold Down; FDR = 0.548; PValue = 0.293; mean CPM = 0.9359; fibroblast growth factor 18
FOXO3: 1.08-fold Down; FDR = 0.55; PValue = 0.294; mean CPM = 48.45; forkhead box O3
GNB1: 1.08-fold Down; FDR = 0.565; PValue = 0.305; mean CPM = 299.4; guanine nucleotide binding protein (G protein), beta polypeptide 1
ITGA1: 1.1-fold Down; FDR = 0.57; PValue = 0.308; mean CPM = 422.3; integrin, alpha 1
RPS6: 1.08-fold Up; FDR = 0.584; PValue = 0.318; mean CPM = 892.5; ribosomal protein S6
PKN1: 1.07-fold Down; FDR = 0.594; PValue = 0.325; mean CPM = 93.47; protein kinase N1
ITGA9: 1.3-fold Down; FDR = 0.595; PValue = 0.326; mean CPM = 1.685; integrin, alpha 9
EFNA5: 1.52-fold Up; FDR = 0.605; PValue = 0.334; mean CPM = 0.9602; ephrin-A5
GNGT2: 1.9-fold Up; FDR = 0.613; PValue = 0.339; mean CPM = 0.8227; guanine nucleotide binding protein (G protein), gamma transducing activity polypeptide 2
COL4A6: 1.4-fold Down; FDR = 0.631; PValue = 0.353; mean CPM = 1.078; collagen, type IV, alpha 6
CHRM2: 1.62-fold Down; FDR = 0.635; PValue = 0.356; mean CPM = 0.8398; cholinergic receptor, muscarinic 2
FGF5: 1.1-fold Down; FDR = 0.646; PValue = 0.364; mean CPM = 54.02; fibroblast growth factor 5
HSP90AB1: 1.07-fold Down; FDR = 0.652; PValue = 0.369; mean CPM = 905.8; heat shock protein 90kDa alpha (cytosolic), class B member 1
VTN: 1.19-fold Up; FDR = 0.669; PValue = 0.382; mean CPM = 2.950; vitronectin
GNB2: 1.06-fold Down; FDR = 0.685; PValue = 0.395; mean CPM = 129.1; guanine nucleotide binding protein (G protein), beta polypeptide 2
ENSMMUP00000014966: 1.43-fold Down; FDR = 0.72; PValue = 0.423; mean CPM = 0.9009; Uncharacterized protein
ITGA4: 1.16-fold Down; FDR = 0.722; PValue = 0.425; mean CPM = 5.425; integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor)
IFNB1: 1.79-fold Up; FDR = 0.731; PValue = 0.433; mean CPM = 0.8526; interferon, beta 1, fibroblast
ITGB6: 1.4-fold Down; FDR = 0.732; PValue = 0.434; mean CPM = 0.9377; Integrin beta
PPP2R2A: 1.06-fold Down; FDR = 0.733; PValue = 0.435; mean CPM = 44.53; protein phosphatase 2, regulatory subunit B, alpha
FGF9: 1.77-fold Up; FDR = 0.74; PValue = 0.441; mean CPM = 0.8485; fibroblast growth factor 9 (glia-activating factor)
HSP90AA1: 1.8-fold Up; FDR = 0.749; PValue = 0.449; mean CPM = 0.8328; heat shock protein 90kDa alpha (cytosolic), class A member 1
GNG13: 1.67-fold Up; FDR = 0.769; PValue = 0.467; mean CPM = 0.8104; guanine nucleotide binding protein (G protein), gamma 13
FGF8: 1.75-fold Down; FDR = 0.783; PValue = 0.48; mean CPM = 0.8245; Uncharacterized protein
YWHAZ: 1.05-fold Down; FDR = 0.785; PValue = 0.482; mean CPM = 341.0; 14-3-3 protein zeta/delta; Uncharacterized protein
CREBL1: 1.05-fold Down; FDR = 0.794; PValue = 0.491; mean CPM = 64.18; activating transcription factor 6 beta
YWHAE: 1.05-fold Up; FDR = 0.799; PValue = 0.496; mean CPM = 281.1; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon polypeptide
PPP2CA: 1.05-fold Up; FDR = 0.8; PValue = 0.497; mean CPM = 62.78; protein phosphatase 2, catalytic subunit, alpha isozyme
IL4R: 1.05-fold Down; FDR = 0.803; PValue = 0.499; mean CPM = 193.5; interleukin 4 receptor
IFNA6: 1.41-fold Down; FDR = 0.807; PValue = 0.504; mean CPM = 0.8019; interferon, alpha 6
FGF14: 1.13-fold Down; FDR = 0.809; PValue = 0.505; mean CPM = 6.007; fibroblast growth factor 14
FLT1: 1.08-fold Down; FDR = 0.849; PValue = 0.558; mean CPM = 28.21; fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor)
CHUK: 1.04-fold Up; FDR = 0.858; PValue = 0.572; mean CPM = 45.34; conserved helix-loop-helix ubiquitous kinase
TCL1A: 1.28-fold Up; FDR = 0.873; PValue = 0.591; mean CPM = 0.7961; T-cell leukemia/lymphoma 1A
MAP2K2: 1.04-fold Down; FDR = 0.877; PValue = 0.596; mean CPM = 274.1; mitogen-activated protein kinase kinase 2
RPS6KB1: 1.04-fold Up; FDR = 0.88; PValue = 0.6; mean CPM = 30.80; Uncharacterized protein
FGF13: 1.24-fold Up; FDR = 0.882; PValue = 0.602; mean CPM = 1.024; Fibroblast growth factor 13 isoform 1; Uncharacterized protein
TCL1B: 1.29-fold Down; FDR = 0.885; PValue = 0.606; mean CPM = 0.8005; T-cell leukemia/lymphoma 1B
YWHAZ: 1.09-fold Up; FDR = 0.888; PValue = 0.61; mean CPM = 3.241; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide
CDK4: 1.04-fold Up; FDR = 0.899; PValue = 0.626; mean CPM = 65.45; cyclin-dependent kinase 4
PPP2R2D: 1.04-fold Down; FDR = 0.899; PValue = 0.629; mean CPM = 19.98; protein phosphatase 2, regulatory subunit B, delta isoform
FGF3: 1.22-fold Down; FDR = 0.903; PValue = 0.641; mean CPM = 0.7938; fibroblast growth factor 3 (murine mammary tumor virus integration site (v-int-2) oncogene homolog)
FGF17: 1.34-fold Down; FDR = 0.903; PValue = 0.662; mean CPM = 0.8230; fibroblast growth factor 17
YWHAB: 1.03-fold Up; FDR = 0.906; PValue = 0.672; mean CPM = 144.6; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta polypeptide
PHLPP1: 1.03-fold Down; FDR = 0.907; PValue = 0.675; mean CPM = 21.33; PH domain and leucine rich repeat protein phosphatase 1
IFNA13: 1.13-fold Up; FDR = 0.908; PValue = 0.677; mean CPM = 0.7960; interferon, alpha 13
CREB3L3: 1.4-fold Down; FDR = 0.908; PValue = 0.679; mean CPM = 0.8407; cAMP responsive element binding protein 3-like 3
FLT4: 1.19-fold Down; FDR = 0.909; PValue = 0.689; mean CPM = 0.8780; fms-related tyrosine kinase 4
LPAR4: 1.13-fold Up; FDR = 0.91; PValue = 0.693; mean CPM = 0.8442; lysophosphatidic acid receptor 4
IFNA8: 1.13-fold Down; FDR = 0.911; PValue = 0.702; mean CPM = 0.7910; interferon, alpha 8
CHRM1: 1.17-fold Up; FDR = 0.916; PValue = 0.717; mean CPM = 0.9294; cholinergic receptor, muscarinic 1
CSF3R: 1.13-fold Down; FDR = 0.921; PValue = 0.723; mean CPM = 0.9331; colony stimulating factor 3 receptor (granulocyte)
FGF19: 1.33-fold Down; FDR = 0.921; PValue = 0.724; mean CPM = 0.8101; fibroblast growth factor 19
G6PC: 1.22-fold Down; FDR = 0.929; PValue = 0.737; mean CPM = 0.8105; glucose-6-phosphatase, catalytic subunit
IL4: 1.27-fold Down; FDR = 0.933; PValue = 0.745; mean CPM = 0.8077; interleukin 4
FASLG: 1.2-fold Down; FDR = 0.941; PValue = 0.757; mean CPM = 0.8088; Fas ligand (TNF superfamily, member 6)
IL2RA: 1.08-fold Up; FDR = 0.945; PValue = 0.766; mean CPM = 0.8493; interleukin 2 receptor, alpha
ENSMMUP00000012063: 1.28-fold Down; FDR = 0.945; PValue = 0.766; mean CPM = 0.8306; Uncharacterized protein
FGF6: 1.15-fold Up; FDR = 0.948; PValue = 0.773; mean CPM = 0.8082; fibroblast growth factor 6
GNG5: 1.02-fold Down; FDR = 0.952; PValue = 0.781; mean CPM = 21.93; guanine nucleotide binding protein (G protein), gamma 5
CCNE2: 1.05-fold Up; FDR = 0.962; PValue = 0.796; mean CPM = 6.415; cyclin E2
IFNA14: 1.22-fold Up; FDR = 0.965; PValue = 0.802; mean CPM = 0.8654; interferon, alpha 14
RAC1: 1.02-fold Down; FDR = 0.967; PValue = 0.805; mean CPM = 28.82; ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)
IFNA4: 1.28-fold Down; FDR = 0.983; PValue = 0.829; mean CPM = 0.8584; interferon, alpha 4
GNG8: 1.11-fold Down; FDR = 0.989; PValue = 0.84; mean CPM = 0.8494; guanine nucleotide binding protein (G protein), gamma 8
LPAR2: 1.06-fold Up; FDR = 0.989; PValue = 0.84; mean CPM = 1.309; lysophosphatidic acid receptor 2
GNGT1: 1.05-fold Up; FDR = 1; PValue = 0.871; mean CPM = 0.8362; guanine nucleotide binding protein (G protein), gamma transducing activity polypeptide 1
COL11A2: 1.03-fold Down; FDR = 1; PValue = 0.872; mean CPM = 2.131; collagen, type XI, alpha 2
GNB5: 1.04-fold Down; FDR = 1; PValue = 0.881; mean CPM = 1.533; guanine nucleotide binding protein (G protein), beta 5
PDGFRB: 1.01-fold Up; FDR = 1; PValue = 0.883; mean CPM = 391.1; platelet-derived growth factor receptor, beta polypeptide
EGF: 1.06-fold Down; FDR = 1; PValue = 0.885; mean CPM = 0.8917; epidermal growth factor
PRLR: 1.06-fold Down; FDR = 1; PValue = 0.889; mean CPM = 1.017; prolactin receptor
COL24A1: 1.04-fold Up; FDR = 1; PValue = 0.898; mean CPM = 1.201; collagen, type XXIV, alpha 1
PPP2R5B: 1.01-fold Down; FDR = 1; PValue = 0.898; mean CPM = 92.91; protein phosphatase 2, regulatory subunit B', beta
IL3: 1.17-fold Down; FDR = 1; PValue = 0.9; mean CPM = 0.8325; Macaca mulatta interleukin 3 (colony-stimulating factor, multiple) (IL3), mRNA.
CASP9: 1.01-fold Up; FDR = 1; PValue = 0.908; mean CPM = 19.86; caspase 9, apoptosis-related cysteine peptidase
TNXB: 1.03-fold Up; FDR = 1; PValue = 0.909; mean CPM = 1.078; tenascin XB
YWHAE: 1.03-fold Up; FDR = 1; PValue = 0.911; mean CPM = 1.303; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon
STK11: 1.01-fold Up; FDR = 1; PValue = 0.918; mean CPM = 47.98; serine/threonine kinase 11
CD19: 1.15-fold Up; FDR = 1; PValue = 0.922; mean CPM = 0.8554; CD19 molecule
NOS3: 1.02-fold Down; FDR = 1; PValue = 0.926; mean CPM = 1.238; nitric oxide synthase 3 (endothelial cell)
THEM4: 1.01-fold Up; FDR = 1; PValue = 0.951; mean CPM = 8.571; thioesterase superfamily member 4
PCK1: 1.05-fold Down; FDR = 1; PValue = 0.961; mean CPM = 0.8008; phosphoenolpyruvate carboxykinase 1 (soluble)
ITGB7: 1.01-fold Down; FDR = 1; PValue = 0.968; mean CPM = 2.025; integrin, beta 7
SYK: 1.11-fold Up; FDR = 1; PValue = 0.977; mean CPM = 0.8420; spleen tyrosine kinase
GYS2: 1.01-fold Down; FDR = 1; PValue = 0.983; mean CPM = 0.7991; glycogen synthase 2 (liver)
TNR: 1.08-fold Down; FDR = 1; PValue = 0.984; mean CPM = 0.8556; tenascin R (restrictin, janusin)
PPP2R3A: No Change; FDR = 1; PValue = 0.988; mean CPM = 15.16; protein phosphatase 2 (formerly 2A), regulatory subunit B'', alpha
FIGF: 1.07-fold Up; FDR = 1; PValue = 0.995; mean CPM = 0.8037; c-fos induced growth factor (vascular endothelial growth factor D)
EIF4E1B: No Change; FDR = 1; PValue = 0.997; mean CPM = 0.7963; eukaryotic translation initiation factor 4E family member 1B
IL2: 1.03-fold Up; FDR = 1; PValue = 0.998; mean CPM = 0.7974; interleukin 2
IFNA1: No Change; FDR = 1; PValue = 0.998; mean CPM = 0.8014; interferon, alpha 1
G6PC2: No Change; FDR = 1; PValue = 1; mean CPM = 0.7816; glucose-6-phosphatase, catalytic, 2
FGF20: No Change; FDR = 1; PValue = 1; mean CPM = 0.7796; fibroblast growth factor 20